BF
BioForce Nanosciences Holdings, Inc.
BFNH · OTC
$9.50 +5.56% (+$0.50)
1M +143.59%
Market Cap $305.3M
P/E Ratio -
Div. Yield -
ROE 84.02%
Bulios Fair Price
$8.32
12.4% downside
Current Price
$9.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BFNH is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 132.55x
PEG N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 4.08%
ROIC 26.65%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 25.41x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
18 /100
Unstable Profitable years 0
Beta -0.43x
EPS volatility 75.65%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BFNH
Online
Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Richard James Kaiser
Employees
3
Headquarters
Virginia Beach